BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9022137)

  • 1. Investigation of c-myc and K-ras amplification in renal clear cell adenocarcinoma.
    Kozma L; Kiss I; Nagy A; Szakáll S; Ember I
    Cancer Lett; 1997 Jan; 111(1-2):127-31. PubMed ID: 9022137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-myc amplification and cluster analysis in human gastric carcinoma.
    Kozma L; Kiss I; Hajdú J; Szentkereszty Z; Szakáll S; Ember I
    Anticancer Res; 2001; 21(1B):707-10. PubMed ID: 11299830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of c-myc oncogene amplification in colorectal cancer.
    Kozma L; Kiss I; Szakáll S; Ember I
    Cancer Lett; 1994 Jun; 81(2):165-9. PubMed ID: 8012933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations and amplification of oncogenes in endometrial cancer.
    Niederacher D; An HX; Cho YJ; Hantschmann P; Bender HG; Beckmann MW
    Oncology; 1999; 56(1):59-65. PubMed ID: 9885379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K-RAS point mutation, and amplification of C-MYC and C-ERBB2 in colon adenocarcinoma.
    Kruszewski W; Kowara R; Rzepko R; Warezak C; Zieliński J; Gryglewski G; Kopacz A; Jastrzebski T; Pawełczyk T
    Folia Histochem Cytobiol; 2004; 42(3):173-9. PubMed ID: 15493579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Human papillomaviruses and cellular oncogenes (c-myc, c-Ha-ras) in cutaneous and mucosal lesions in transplantation recipients].
    Pélisson I; Soler C; Chignol MC; Euvrard S; Chardonnet Y
    Bull Cancer; 1992; 79(5):471-82. PubMed ID: 1330099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Overexpression of c-myc, c-fos and Harvey ras oncogenes in renal cancers--analysis at the messenger RNA levels].
    Kunimi K; Uchibayashi T; Hisazumi H
    Nihon Hinyokika Gakkai Zasshi; 1991 Dec; 82(12):1924-9. PubMed ID: 1779495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characterization of oncogenes (K, N-ras and N, c-myc) in subcloned cell lines (KCC-1a and 1b) derived from same endometrial carcinoma presenting well differentiated adenocarcinoma and clear cell carcinoma].
    Kataoka A; Yakushiji M; Ohbuchi T; Morimitsu Y; Kojiro M
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Oct; 43(10):1317-22. PubMed ID: 1955783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-myc and K-ras-2 oncogenes in B-cell chronic lymphocytic leukemia with del(12)(p13).
    Wang TY; Samples DM; Dabdoub R; Prakash O
    Cancer Genet Cytogenet; 1991 Jan; 51(1):125-30. PubMed ID: 1984840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of epidermal growth factor receptor overexpression, K-ras point mutation and c-myc amplification in the carcinogenesis of non-small cell lung cancer.
    Sekine I; Takami S; Guang SG; Yokose T; Kodama T; Nishiwaki Y; Kinoshita M; Matsumoto H; Ogura T; Nagai K
    Oncol Rep; 1998; 5(2):351-4. PubMed ID: 9468555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the presence of distant metastasis associated with c-myc amplification in gastric cancer?
    Hajdú J; Kozma L; Kiss I; Szentkereszty Z; Szakáll S; Ember I
    Acta Chir Hung; 1997; 36(1-4):119-21. PubMed ID: 9408311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amplification of proto-oncogenes C-myc, C-N-ras, C-Ki-ras, C-erbB2 in ovarian carcinoma].
    Bian M; Fan Q; Huang S
    Zhonghua Fu Chan Ke Za Zhi; 1995 Jul; 30(7):406-9. PubMed ID: 7587576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression and amplification of c-myc and c-Ha-ras oncogenes in pleomorphic salivary adenoma.
    Xue H; Situ ZQ; Wang CJ; Wu JZ
    Chin Med J (Engl); 1993 Jan; 106(1):22-5. PubMed ID: 8389270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The amplification of c-myc, N-ras, c-erb B oncogenes in ovarian malignancies].
    Xin XY
    Zhonghua Fu Chan Ke Za Zhi; 1993 Jul; 28(7):405-7, 442. PubMed ID: 8287725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the ras protooncogenes are rare events in renal cell cancer.
    Rochlitz CF; Peter S; Willroth G; de Kant E; Lobeck H; Huhn D; Herrmann R
    Eur J Cancer; 1992; 28(2-3):333-6. PubMed ID: 1591047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of minisatellite instability with c-myc amplification and K-ras mutation in methylcholanthrene-induced mouse sarcomas.
    Niwa O; Kamiya K; Furihata C; Nitta Y; Wang Z; Fan YJ; Ninomiya Y; Kotomura N; Numoto M; Kominami R
    Cancer Res; 1995 Dec; 55(23):5670-6. PubMed ID: 7585652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple genetic lesions in laryngeal squamous cell carcinomas.
    Fracchiolla NS; Pignataro L; Capaccio P; Trecca D; Boletini A; Ottaviani A; Polli E; Maiolo AT; Neri A
    Cancer; 1995 Mar; 75(6):1292-301. PubMed ID: 7882279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogenous amplification of myc family oncogenes in small cell lung carcinoma.
    Noguchi M; Hirohashi S; Hara F; Kojima A; Shimosato Y; Shinkai T; Tsuchiya R
    Cancer; 1990 Nov; 66(10):2053-8. PubMed ID: 2171744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplifications of proto-oncogenes in ovarian carcinoma.
    Bian M; Fan Q; Huang S; Ma J; Lang J
    Chin Med J (Engl); 1995 Nov; 108(11):844-8. PubMed ID: 8585978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ; Frierson HF; Williams ME
    Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.